BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2017
View Archived Issues
Australian grant supports neuroblastoma research
Read More
Can-Fite Biopharma set to begin phase III ACRobat study of piclidenoson
Read More
PTC Therapeutics announces annual STRIVE grant award program for Duchenne muscular dystrophy
Read More
Novel nucleoside-modified mRNA vaccine elicits rapid and durable protective immunity against ZIKV
Read More
BioRestorative Therapies receives FDA clearance to initiate phase II trial of BRTX-100
Read More
Mitsubishi Tanabe Pharma updates pipeline progress of third quarter of fiscal 2016
Read More
FibroGen presents promising phase I results for FG-3019 in patients with pancreatic cancer
Read More
COMPASS trial of Xarelto stopped early for efficacy
Read More
First rabbit para-renal cancer model generated using VX2 tumors
Read More
AbbVie initiates phase I study of ABBV-951 for Parkinson's disease
Read More
Novo Nordisk presents highlights of fourth quarter 2016
Read More
FDA advisory committee meeting not needed for Portola Pharmaceuticals' betrixaban NDA
Read More
hVIVO reports data from two phase IIa studies of PrEP Biopharm's PrEP-001
Read More
Epinomics collaborates with Parker Institute for Cancer Immunotherapy
Read More
Spotlight Innovation hires CRO for further preclinical testing of candidate for SMA
Read More
Merck & Co. describes novel adenosine A2A receptor antagonists
Read More
Jazz initiates phase II study of JZP-110 to treat excessive sleepiness in Parkinson's disease
Read More
Altered immunity-related gene expression in adolescents with chronic fatigue syndrome
Read More
MeiraGTx gives update on its clinical trials in achromatopsia and Leber congenital amaurosis
Read More
Oncoceutics' ONC-201 granted U.S. orphan drug status for mantle cell lymphoma
Read More
Anti-HER2 bispecific antibody ZW-25 receives FDA orphan designation for gastric cancer
Read More
Acorda Therapeutics reports phase III data on CVT-301 in Parkinson's disease
Read More
Chrysalis Biotherapeutics begins contract with NIAID for TP-508 as nuclear countermeasure
Read More